[300+ Pages Report] The market for INR test metres is anticipated to reach US$ 1.3 billion by the end of 2022, growing at a CAGR of 6.3 percent, and surpassing US$ 2.4 billion by 2032. With a market share of approximately 79.7% in 2021, the devices segment dominated the global INR test metre market in …
Category Archives: Healthcare Trends
Intelligent Prosthetics Market is expected to reach a valuation of US$ 1.35 Billion by 2032, at a CAGR of 6.1% | FMI
As per Future Market Insights, the global Intelligent Prosthetics Market market was around US$ 707.8 Million in 2021 and is projected to exhibit a CAGR of close to 6.1% over the forecast period (2022-2032), with an estimated valuation of US$ 1.35 Billion in 2032. The intelligent prosthetics market is growing due to the rapid adoption of high-tech-based devices, which is improving …
Sterilants Market is projected to reach a valuation of US$ 4244.1 million by 2033, at a CAGR of 6% | FMI Study
The Sterilants Market is expected to grow from US$ 2361.627 million in 2023 to US$ 4244.1 million by 2033. During the analysis period, this market is expected to grow at a CAGR of 6%. Industries and healthcare facilities must follow the sterilization process. In the sterilants market, effective and compatible sterilants or sporicidal agents have …
CMO/CDMO Market is threatened by the risk of intellectual property theft | Says FMI Analyst
As more pharmaceutical businesses contemplate outsourcing services, the need for services from contract manufacturing and contract development manufacturing organizations will grow. Future Industry Insights (FMI) believes that the CMO/CDMO Market has enormous potential for growth in the foreseeable future. The increased need for generic pharmaceuticals and biologics will fuel market expansion. Contract manufacturing accounts for …
Enzyme Replacement Therapy Market is predicted to attain an estimated value of US$ 13.8 Billion by 2028 | FMI
The Enzyme Replacement Therapy Market is anticipated to reach a value of US$ 9.3 billion in 2022 and, with a CAGR of 6.7%, US$ 13.8 billion by the end of 2028. Revenue from enzyme replacement therapy (ERT) represents over 63% of the market for hormone replacement globally. The usage of enzyme replacement therapy has been …
Gynaecological Examination Chairs Market in North America is expected to reach USD 312.1 Million by 2028 | FMI
According to a Future Market Insights (FMI) analysis, the Gynaecological Examination Chairs Market is valued at US$ 531.6 Million in 2021 and is predicted to reach US$ 852.3 Million by 2028, representing a cumulative CAGR of 6.9% over the forecast period (2022-2028). In 2021, the global market for gynaecological examination chairs will account for around …
Varicella Zoster Infection Treatment Market is expected to reach a valuation of US$ 2.05 Billion by 2028, at a CAGR of 4.1%
The global Varicella Zoster Infection Treatment Market is predicted to be worth more than US$ 1.5 billion in 2020, with a CAGR of 4.1% expected to reach US$ 2.05 billion by 2028. According to Future Market Insights, acyclovir will account for more than 55.7% of the global varicella zoster infection treatment market in 2022. Acute …
Hepatitis B Diagnostic Tests Market is expected to grow at a 6.4% CAGR by 2028, attaining a valuation of US$ 1.26 Million
Despite the COVID-19 impact, the global Hepatitis B Diagnostic Tests Market grew at a solid year-on-year (YoY) rate, reaching a valuation of roughly US$ 872.5 Million in 2022. With the rising incidence of hepatitis B globally, the total market is expected to grow at a CAGR of 6.4% between 2022 and 2028, achieving a valuation of US$ …
Insulin Delivery Pens Market in Latin America is predicted to grow at a 7.6% CAGR by 2032 | FMI
The global Insulin Delivery Pens Market is predicted to be worth US$ 22.4 billion by the end of 2022 and to grow at an 8.0% CAGR to be worth US$ 48.6 billion by the end of 2032. According to a recent Future Market Insights analysis, smart insulin pens by-products are the market leaders, accounting for …
General Anesthesia Drugs Market to reach a valuation of US$ 6.7 Billion by the year 2032 | FMI
[Report of 182 Pages] The General Anaesthesia Drugs Market is expected to be worth US$ 4.7 billion by the end of 2022, and to grow at a CAGR of 3.4% to be worth US$ 6.7 billion by the end of 2032. According to a recent Future Market Insights study, the Propofol drug class will lead the …